Paliperidone Palmitate

PALIPERIDONE PALMITATE-
TOLMAR Inc.

PRINCIPAL DISPLAY PANEL

39 mg
(click image for full-size original)

78 mg
(click image for full-size original)
117mg
(click image for full-size original)
156mg
(click image for full-size original)
234mg
(click image for full-size original)
PALIPERIDONE PALMITATE
paliperidone palmitate kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:63646-711
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-711-39 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 SYRINGE 0.25 mL
Part 1 of 1
PALIPERIDONE PALMITATE
paliperidone palmitate injection, suspension, extended release
Product Information
Item Code (Source) NHRIC:63646-701
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PALIPERIDONE PALMITATE (PALIPERIDONE) PALIPERIDONE PALMITATE 39 mg in 0.25 mL
Inactive Ingredients
Ingredient Name Strength
POLYSORBATE 20
POLYETHYLENE GLYCOL 4000
CITRIC ACID MONOHYDRATE
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-701-39 0.25 mL in 1 SYRINGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 01/01/2022
PALIPERIDONE PALMITATE
paliperidone palmitate kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:63646-712
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-712-78 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 SYRINGE 0.5 mL
Part 1 of 1
PALIPERIDONE PALMITATE
paliperidone palmitate injection, suspension, extended release
Product Information
Item Code (Source) NHRIC:63646-702
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PALIPERIDONE PALMITATE (PALIPERIDONE) PALIPERIDONE PALMITATE 78 mg in 0.5 mL
Inactive Ingredients
Ingredient Name Strength
POLYSORBATE 20
POLYETHYLENE GLYCOL 4000
CITRIC ACID MONOHYDRATE
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-702-78 0.5 mL in 1 SYRINGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 01/01/2022
PALIPERIDONE PALMITATE
paliperidone palmitate kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:63646-713
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-713-17 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 SYRINGE 0.75 mL
Part 1 of 1
PALIPERIDONE PALMITATE
paliperidone palmitate injection, suspension, extended release
Product Information
Item Code (Source) NHRIC:63646-703
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PALIPERIDONE PALMITATE (PALIPERIDONE) PALIPERIDONE PALMITATE 117 mg in 0.75 mL
Inactive Ingredients
Ingredient Name Strength
POLYSORBATE 20
POLYETHYLENE GLYCOL 4000
CITRIC ACID MONOHYDRATE
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-703-17 0.75 mL in 1 SYRINGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 01/01/2022
PALIPERIDONE PALMITATE
paliperidone palmitate kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:63646-710
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-710-56 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 SYRINGE 1 mL
Part 1 of 1
PALIPERIDONE PALMITATE
paliperidone palmitate injection, suspension, extended release
Product Information
Item Code (Source) NHRIC:63646-700
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PALIPERIDONE PALMITATE (PALIPERIDONE) PALIPERIDONE PALMITATE 156 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
POLYSORBATE 20
POLYETHYLENE GLYCOL 4000
CITRIC ACID MONOHYDRATE
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-700-56 1 mL in 1 SYRINGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 01/01/2022
PALIPERIDONE PALMITATE
paliperidone palmitate kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:63646-714
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-714-34 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 SYRINGE 1.5 mL
Part 1 of 1
PALIPERIDONE PALMITATE
paliperidone palmitate injection, suspension, extended release
Product Information
Item Code (Source) NHRIC:63646-704
Route of Administration INTRAMUSCULAR DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PALIPERIDONE PALMITATE (PALIPERIDONE) PALIPERIDONE PALMITATE 234 mg in 1.5 mL
Inactive Ingredients
Ingredient Name Strength
POLYSORBATE 20
POLYETHYLENE GLYCOL 4000
CITRIC ACID MONOHYDRATE
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM HYDROXIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:63646-704-34 1.5 mL in 1 SYRINGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 01/01/2022
Labeler — TOLMAR Inc. (791156578)
Establishment
Name Address ID/FEI Operations
TOLMAR 1201 Cornerstone LLC 079112310 analysis (63646-711), analysis (63646-701), analysis (63646-712), analysis (63646-702), analysis (63646-713), analysis (63646-703), analysis (63646-710), analysis (63646-700), analysis (63646-714), analysis (63646-704), label (63646-711), label (63646-701), label (63646-712), label (63646-702), label (63646-713), label (63646-703), label (63646-710), label (63646-700), label (63646-714), label (63646-704), manufacture (63646-711), manufacture (63646-701), manufacture (63646-712), manufacture (63646-702), manufacture (63646-713), manufacture (63646-703), manufacture (63646-710), manufacture (63646-700), manufacture (63646-714), manufacture (63646-704), pack (63646-711), pack (63646-701), pack (63646-712), pack (63646-702), pack (63646-713), pack (63646-703), pack (63646-710), pack (63646-700), pack (63646-714), pack (63646-704)

Revised: 01/2022 TOLMAR Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.